FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to antibacterial therapy, namely to medications for infectious diseases caused by multiresistant bacteria. The invention can be used for treatment of hospital mainly, and also severe heavy and extremely severe infectious diseases. The preparation represents mixed cephalosporin antibiotic Cefepime and beta-lactamase inhibitor Sulbactam in the ratio 1:1 to 1:2, respectively.
EFFECT: application of the preparation allows improving clinical effectiveness for infectious diseases essentially.
4 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR THE TREATMENT OF INFECTIONS CAUSED BY MULTI-RESISTANT BACTERIA, INCLUDING THOSE PRODUCING CARBAPENEMASE | 2022 |
|
RU2793587C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING BETA-LACTAM ANTIBIOTIC, SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2569059C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFECTIOUS DISEASES CAUSED BY MULTI-RESISTANT BACTERIA | 2011 |
|
RU2455989C1 |
| COMPOSITIONS CONTAINING ANTIBACTERIAL AGENT AND TAZOBACTAM | 2011 |
|
RU2593363C2 |
| BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY | 2015 |
|
RU2678124C2 |
| BETA-LACTAMASE, METHOD OF ITS MODIFICATION, OBTAINING AND APPLICATION | 2011 |
|
RU2570551C2 |
| ANTIMICROBIAL AGENT | 2010 |
|
RU2447896C1 |
| MEDICATION FOR TREATMENT OF INFECTIOS DISEASES | 2010 |
|
RU2424801C1 |
| 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND USING THEM FOR TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2578370C2 |
| 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND THEIR APPLICATION FOR BACTERIAL INFECTIONS TREATMENT | 2012 |
|
RU2636147C1 |
